Dr. Daniel X. Hammer

Fellow Member | Deputy Director, Division of Biomedical Physics at US Food and Drug Administration
Hammer, Daniel X.
SPIE Leadership: Retrieving Data, please wait...
SPIE Membership: 24.1 years total | 19.1 years voting
SPIE Awards: Fellow status | Senior status
SPIE Involvement: Retrieving Data, please wait...
Area of Expertise: Adaptive optics, Optical coherence tomography, Retinal imaging, Vision science, Biomedical optics, Neuroimaging
Websites: Company Website
Contact Details:
Sign In to send a private message or view contact details

Profile Summary

Daniel X. Hammer received a BS in Electrical Engineering from Rensselaer Polytechnic Institute in 1991 and a MS and PhD from University of Texas (UT) at Austin in 1998 and 2001. He has over 25 years’ experience in the invention, design, development, and application of biomedical optics and instrumentation to a broad range of interdisciplinary research programs.

He was an Air Force officer and experimental researcher in the Air Force Research Laboratory at Brooks AFB, San Antonio TX from 1992 to 1996. There he studied nonlinear optical interactions with aqueous media and helped perform experiments that set the ANSI laser safety standard for the ultrashort pulse laser regime. In graduate school at UT under the direction of A.J. Welch, he studied the infrared pit organ of the pyrophilic beetle, Melanophila acuminata. He worked for Physical Sciences Inc. in Andover MA from 2001 to 2012, where he led the Biomedical Imaging Area in the development of line of clinical and research adaptive optics (AO) instruments. Clinical prototype AO devices developed under Dr. Hammer’s guidance are operational in 8 clinics and research laboratories across the U.S. and Canada. Dr. Hammer is currently the Deputy Director of the Division of Biomedical Physics in the Office of Science and Engineering Laboratories, Center of Devices and Radiological Health, FDA in Silver Spring MD. He leads several research teams in vision science and neurophotonics in the medical device regulatory science space. He is investigating the application of multimodal adaptive optics to glaucoma, macular degeneration, and other retinal disease. He is also examining the long-term response to cortical implants using OCT and two-photon microscopy.

Dr. Hammer is co-editor of "Advances in Optical Imaging for Clinical Medicine" and has 15 patents and disclosures, over 85 peer-reviewed publications, and over 150 other papers and publications. He is a member of AIMBE (fellow), ARVO, OSA, and SPIE (fellow).

SPIE Volunteer Activities

Retrieving Data, please wait...

Upcoming Presentations

Most Recent | Show All
Retrieving Data, please wait...

Publications

Most Recent | Show All
Retrieving Data, please wait...

Conference Committee Involvement

Most Recent | Show All
Retrieving Data, please wait...

Course Instructor

Most Recent | Show All
Retrieving Data, please wait...
PREMIUM CONTENT
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?
close_icon_gray